Tag:

Infectious Diseases

COVID-19: Omicron Surge Affecting Staffing Levels For Essential Workers COVID-19: Omicron Surge Affecting Staffing Levels For Essential Workers
Covid-19: Omicron Surge Affecting Staffing Levels For Essential Workers The spread of the more-transmissible Omicron COVID-19 variant is leading to staffing shortages for some essential employers who have been hit hardest by the winter surge of the virus. Essential employees have been forced to call out of work en masse in recent weeks due to positive Omicron infections that have led to staffing shortages for first responders, healthcare workers, supermarket workers, flight crews, and other key professions. The shortages have led to hundreds of canceled flights, closed restaurants, and short-staffed retail stores, leaving workers frustrated and fatigued af…
COVID-19: New Study Finds Significant Virus Spread Among Deer Population COVID-19: New Study Finds Significant Virus Spread Among Deer Population
Covid-19: New Study Finds Significant Virus Spread Among Deer Population A new study has found widespread COVID-19 infections among deer populations in Iowa. Researchers from the Penn State University found that more than 80 percent of white-tailed deer sampled in parts of Iowa between December of 2020 and January of 2021 tested positive for COVID-19, according to an announcement from the university on Wednesday, Nov. 3. “We found that 80 percent of the sampled deer in December were positive for SARS-CoV-2, which proportionally represents about a 50-fold greater burden of positivity than what was reported at the peak of infection in humans at the time,” said Sur…
COVID-19: Drugmaker To Seek Emergency Approval For Pill To Treat Virus COVID-19: Drugmaker To Seek Emergency Approval For Pill To Treat Virus
Covid-19: Drugmaker To Seek Emergency Approval For Pill To Treat Virus A new pharmaceutical company is throwing its hat in the ring as the country continues its fight against COVID-19. Merck and Ridgeback Biotherapeutics announced on Friday, Oct. 1 that it is planning to apply for federal emergency approval of a pill that can reportedly help prevent hospitalizations and deaths in COVID-19 patients. According to the company, trials have found that the pill - dubbed molnupiravir - could potentially reduce the risk of hospitalization or death in patients with mild to moderate COVID-19 by approximately 50 percent. The results of the late-stage trial have bee…